Navigation Links
Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
Date:8/12/2008

hnology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "expect"; "potential" or "may"; or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety issues resulting from the administration of MEDI-545 in patients, as well as risks detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and its quarterly re
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
7. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
8. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 The board ... LLY ) has declared a dividend for the ... outstanding common stock. The dividend is ... the close of business on August 15, 2013. ... growing portfolio of pharmaceutical products by applying the latest ...
(Date:6/18/2013)... 18, 2013 New-generation electronic designs are ... and lightweight. Simultaneously, circuitry is increasing the number ... to which it performs at. Connecting cables from ... military equipment, such as cameras or detectors, must ... nano-circular connectors include custom cable designs for high-quality ...
(Date:6/18/2013)... -- Healthgrades, the leading online resource that helps consumers ... hospitals, today issued the Healthgrades Women,s Health ... to Get Your Best Outcome . The report, which ... gynecologic surgery, as well as hospitals that excelled ... the most common hospital-based conditions and procedures, urges ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4
... CARLOS, Calif., Sept. 21 NeurogesX, Inc.,(Nasdaq: ... enrollment in study,C119, a second Phase 3 clinical ... treatment of painful HIV-distal sensory polyneuropathy,(HIV-DSP). NGX-4010 is ... Previously completed Phase 3 trials demonstrated that a,single, ...
... the American Journal of Nephrology -, DEERFIELD, Ill., ... its Phase III data on VAPRISOL was published in,the ... this study,VAPRISOL showed a significant increase in serum sodium ... that,occurs when the body,s sodium level falls below normal. ...
Cached Medicine Technology:NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 2NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 3NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 2Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 3Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 5
(Date:6/19/2013)... Bonita ™ Hair Skin and Nail ... many conditions that range from hair breakage and split ... has now developed a single serving, rapid response tablet ... only stronger than the original Bonita formula, but also ... , Justin Zehrung, Vice President of Essential Source ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The ... for Disease Control of the 2500 to 3000 citizens, ... cancer called mesothelioma this year, about one third will ... Navy Veteran diagnosed with this asbestos exposure form of ... them instant access to the nations most skilled mesothelioma ...
(Date:6/19/2013)... 19, 2013 Faith4Kidz is starting a new ... Peace". Faith4Kidz would like help showing support for kids to ... are more positive. Check out the website, http://www.gracenfaith.com ... logo is red, white and blue stars as a symbol ... throughout history as well as the stars we should encourage ...
(Date:6/18/2013)... June 18, 2013 Exposed Skin Care has ... of acne suffers of all ages finally achieve the clear, ... treatment products, this new acne clearing system combines the power ... prevent new acne from forming. , After a ... these products are some of the most effective available on ...
(Date:6/18/2013)... Looking for a way to break out of the ... IWALKAWAKE is a guide to unlocking one’s true potential through ... on harnessing the powerful and abundant spiritual presence that is ... guide to finding one’s true purpose and potential. These nine ... to reach their true potential. The awakenings deal with subjects ...
Breaking Medicine News(10 mins):Health News:Essential Source ® Improves On Best Selling Bonita ™ Hair Skin and Nail Product 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3
... ... BWIN™, and WaveRider® Product Lines , ... (PRWEB) November 6, 2009 -- WAV, Inc., the ... it has partnered with Vecima Networks Inc. (TSX:VCM), a leading provider of equipment ...
... of the National Council on Aging: , WASHINGTON, Nov. 6 ... pass the Affordable Health Care for America Act (H.R. 3962), ... goal of accessible, quality health care for Americans of all ... the bill is a good deal for America,s seniors. H.R. ...
... Lockton Benefit Group, the health and welfare benefits ... employer health cost reduction initiatives through health risk ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090415/CG99351LOGO ) , Lockton ... support Lockton,s clients with: , Health promotion ...
... group of patients with severe Graves, eye disease experienced ... following treatment with the drug rituximab. Inflammation around ... significantly reduced. The same patients had not previously responded ... Raymond S. Douglas, M.D., Ph.D., an oculoplastics specialist ...
... , Award-Winning Company is Maker of The Thermal Angel ... 6 Estill Medical Technologies, a family-owned Texas company that ... Infusion Warmer , was named one of the area,s ... Co-founded by the Caruth Institute for Entrepreneurship in 1990, the ...
... both sides of the Atlantic applaud President Barack Obama ... Union (EU) Presidency, for establishing a transatlantic task force ... that threatens patient safety and public health worldwide. During ... Obama and Prime Minister Reinfeldt joined forces to address ...
Cached Medicine News:Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3Health News:NCOA Supports H.R. 3962, the Affordable Health Care for America Act 2Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 2Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 3Health News:Researchers find new way to attack inflammation in Graves' eye disease 2Health News:Life Saving Estill Medical Technologies Receives Prestigious 'Dallas 100(TM)' Award 2Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 2Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 3Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 4
... is a completely new concept ... use of optic technology for ... applying touch-less vibration system (Patent ... ergonomic user friendly, novel design ...
... A human blood based control designed ... needs, from Point of Care Testing (POCT) ... labs. GlycoHemosure is intended as a basic ... procedures for the quantitation of hemoglobin A1c. ...
SPOT RT KE and RT SE digital camera lines provide maximum performance in a mid-line scientific camera system....
... ResMeds premium APAP device in the S8 ... patients pressure needs on a breath-by-breath basis. ... fully integrated humidification and also include remote ... patients time by reducing medical visits. Like ...
Medicine Products: